Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Larynx-preserving treatment strategy for patients with resectable cervical esophageal squamous cell carcinoma.
Authors
Yasuhiro Tsubosa
Division of Esophageal Surgery, Shizuoka Cancer Center, Shizuoka, Japan
Yasuhiro Tsubosa , Masazumi Inoue , Kazunori Tokizawa , Shuhei Mayanagi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 311)
DOI
10.1200/JCO.2024.42.3_suppl.311
Abstract #
311
Poster Bd #
E11
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer.
First Author: Junya Kitadani
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
First Author: yueyun chen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study.
First Author: Jhe-Cyuan Guo
Poster
2023 ASCO Breakthrough
Impact of pathological response and recurrence pattern on the survival of patients who develop recurrence from neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma (ESCC).
First Author: Chien Huai Chuang